Researchers are studying ways to eliminate fat cells instead of shrinking them, which could help with regain after weight loss. The source gives no study details.
Recap by typeshit. Post by @astrophilesz on Instagram.
A retrospective study in Cureus looks back at how well once-weekly semaglutide worked, and how safe it was, for teenagers with obesity.
Presented at Sleep Europe 2026, both trials found retatrutide lowered the apnea-hypopnea index more than placebo, including in people with type 2 diabetes.
Endpoints News
Endpoints reports Eli Lilly is building a case for its triple agonist beyond obesity, where a launch is expected next year, with sleep apnea next in line.
Observational data link GLP-1 drugs to fewer cases of some cancers, but trials have yet to show they prevent cancer or help survival after a diagnosis.
Novo Nordisk shared a new analysis of its next-generation experimental drug, with results focused on women with obesity or overweight.
In a JAMA Network Open survey study of 3,615 adults, GLP-1 use was 20.5% with a cancer history versus 26.5% without, about 30% lower odds.
Loading…